Summary:
Tapia Internal Medicine is looking for participants diagnosed with Type 2 Diabetes who are currently using Metformin to participate in a study investigating a once-weekly, self-injectable treatment.
Qualified Participants Must:
Between 18 and 64 years old
Have been diagnosed with Type 2 Diabetes for at least 6 months
Currently on a stable dose of Metformin
Qualified Participants May Receive: